These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31047311)

  • 1. Inadvertent Expulsion of Fluocinolone Acetonide Intravitreal Implant during Pars Plana Vitrectomy.
    Wang H; Hardin J; Kaintatzis A; Uwaydat SH; Sallam AB
    Ophthalmol Retina; 2018 Jan; 2(1):75-77. PubMed ID: 31047311
    [No Abstract]   [Full Text] [Related]  

  • 2. BILATERAL INTRAVITREAL 0.19-MG FLUOCINOLONE ACETONIDE IMPLANT FOR PERSISTENT NONDIABETIC CYSTOID MACULAR EDEMA AFTER VITRECTOMY.
    Ong SS; Walter SD; Chen X; Thomas AS; Finn AP; Fekrat S
    Retin Cases Brief Rep; 2021 May; 15(3):261-265. PubMed ID: 30015770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.
    Pessoa B; Coelho J; Correia N; Ferreira N; Beirão M; Meireles A
    Ophthalmic Res; 2018; 59(2):68-75. PubMed ID: 29248913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
    Dayani PN; Chow J; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2011 Nov; 152(5):849-56.e1. PubMed ID: 21794844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    Holbrook JT; Sugar EA; Burke AE; Vitale AT; Thorne JE; Davis JL; Jabs DA;
    Am J Ophthalmol; 2016 Apr; 164():29-36. PubMed ID: 26748056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous band formation and the sustained-release, intravitreal fluocinolone (Retisert) implant.
    Galor A; Margolis R; Kaiser PK; Lowder CY
    Arch Ophthalmol; 2007 Jun; 125(6):836-8. PubMed ID: 17562999
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
    Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
    Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DISLODGEMENT OF FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT INTO THE INFUSION CANNULA DURING VITRECTOMY FOR RETINAL DETACHMENT.
    Andreatta W; Elaraoud I; Mitra A
    Retin Cases Brief Rep; 2020; 14(3):215-217. PubMed ID: 29210960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleral thickness following fluocinolone acetonide implant (Retisert).
    Taban M; Lowder CY; Ventura AA; Sharma S; Nutter B; Hayden BC; Dupps WJ; Kaiser PK
    Ocul Immunol Inflamm; 2010 Aug; 18(4):305-13. PubMed ID: 20482407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iluvien Implantation for Uveitis and Uveitic Macular Edema.
    Reddy AK; Burkholder BM; Khan IR; Thorne JE
    Ocul Immunol Inflamm; 2018; 26(2):315-316. PubMed ID: 27736275
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber.
    Li AS; Nguyen HV; Do DV
    JAMA Ophthalmol; 2020 Oct; 138(10):e201388. PubMed ID: 33030543
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluocinolone Acetonide Intravitreal Implant in the Visual Axis.
    Moisseiev E; Morse LS
    JAMA Ophthalmol; 2016 Sep; 134(9):1067-8. PubMed ID: 27367921
    [No Abstract]   [Full Text] [Related]  

  • 14. Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert).
    Rofagha S; Prechanond T; Stewart JM
    Ocul Immunol Inflamm; 2013; 21(1):77-8. PubMed ID: 23323586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluocinolone acetonide intravitreal implant (Retisert
    Leinonen S; Immonen I; Kotaniemi K
    Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
    Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
    Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
    Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA;
    Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
    Pearson PA; Comstock TL; Ip M; Callanan D; Morse LS; Ashton P; Levy B; Mann ES; Eliott D
    Ophthalmology; 2011 Aug; 118(8):1580-7. PubMed ID: 21813090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.
    Drugs R D; 2005; 6(2):116-9. PubMed ID: 15777105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.